| INTRODUCTION
Since the first baby was born as a result of in vitro fertilization (IVF) in the UK in 1978, 1 assisted reproductive technology (ART) has been used as infertility treatment globally. More than 1 million babies worldwide were reportedly born as a result of ART between 2008 and 2010. 2 In Japan, the first baby born after IVF was reported by
Tohoku University in 1983. 3 Since then, the number of ART cycles has T A B L E 1 Trends in the number of registered cycles, egg retrievals, pregnancies, and neonates by in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and frozen-thawed embryo transfer cycle in Japan from 1985 to 2015 
| MATERIALS AND METHODS
Since 2007, JSOG has requested that all ART clinics and hospitals register cycle-specific information for all ART cycles, including patient characteristics, information on ART treatment, and pregnancy and obstetric outcomes. Details on the information that has been collected in the registry have been reported previously. 4 For the period from 1 January to 31 December, 2015, JSOG requested that information on each treatment cycle that was performed at all participating institutions be registered via an online registry system by the end of November, 2016. This study was approved by the Institutional Review Board at the National Center for Child Health and Development, Tokyo, Japan, and the Ethical Review Board at JSOG.
Using the ART registry database in 2015, a descriptive analysis was performed to investigate the characteristics and treatment outcomes of registered fresh and frozen cycles. The number of registered cycles, egg retrievals, embryo transfer (ET) cycles, fresh cycles with freeze-all embryos or oocytes, pregnancies, and neonates was compared with that in previous years. The characteristics of the registered cycles and treatment outcomes were described for the fresh and the frozen cycles. The treatment outcomes included the pregnancy, miscarriage, and live birth rates, multiple pregnancies, and pregnancy outcomes for an ectopic pregnancy, intrauterine pregnancy coexisting with an ectopic pregnancy, artificial abortion, stillbirth, and fetal reduction.
Furthermore, the treatment outcomes of pregnancy and the live birth and miscarriage rates were analyzed by patient age finally; the treatment outcomes for frozen-thawed ET using frozen-thawed oocytes also were investigated.
| RESULTS
There Singleton, twin, triplet, and quadruplet pregnancies were defined according to the number of gestational sacs in utero. ET, embryo transfer; GIFT, gamete intrafallopian transfer; ICSI, intracytoplasmic sperm injection; IVF-ET, in vitro fertilization-embryo transfer; SET, single embryo transfer; TESE, testicular sperm extraction.
ET cycles, of which 169 898 were performed and from which 56 355 pregnancies resulted (the pregnancy rate per frozen-thawed ET = 33.2%). The miscarriage rate per pregnancy was 26.4%, resulting in a 23.0% live birth rate per ET. Single ET was performed at a rate of 81.8% and the singleton pregnancy rate was 96.8%. Among the live births, 96.4% were singletons.
The total number of registered ET cycles, the number and rate of pregnancies, and the rate of live births and miscarriages by patient age in 2015 are shown in Table4. The distribution of the pregnancy, live birth, and miscarriage rates for each age is shown in Figure2. The pregnancy rate per ET exceeded 40% up to 32 years of age and gradually fell below 30% after 39 years of age and below 10% after 44 years of age. The miscarriage rate per pregnancy was 17% for those who were under 32 years of age and it gradually increased with an increase in patient age. The miscarriage rate was 34.6% for those who were 40 years of age and 52.4% for those who were 43 years of age. The live birth rate per registered cycle was ~20% up to 33 years of age and it decreased to 9.1% by 40 years of age and 3.0% by 43 years of age.
The treatment outcomes for ET using frozen-thawed oocytes are shown in Table 5 . The total number of ETs using frozen oocytes was 135 cycles, of which 15 cycles resulted in a pregnancy (the pregnancy rate per ET = 11.1%). The miscarriage rate per pregnancy was 26.7%, resulting in an 8.1% live birth rate per ET. Health, Labour and Welfare, the mean maternal age at the time of the first birth is 30.7 years. 5 Maternal age was the most important factor to determine the probability of a live birth after ART. As the pregnancy and live birth rates decreased as the maternal age increased (Table 4) , the number of ET cycles resulting in a live birth theoretically would exceed that in mothers of a younger age.
| DISCUSSION
Single ET was performed at a rate of almost 80%, both for fresh and frozen cycles. In 2008, JSOG recommended restricting the number of ETs to one in order to prevent multiple pregnancies but double ET was allowed for women who are older than 35 years of age or for women who have experienced recurrent implantation failure. As a result, the number of single ETs has increased from 49.9% in 2007 to 73.0% in 2010, while multiple pregnancies have decreased from 11.5% in 2007 to 4.8% in 2010. 6 The single ET policy has been credited with improving other indicators of perinatal outcomes in Japan. 7 There was a significant increasing trend in the number of fresh cycles with freeze-all embryos and oocytes (Table 1) . Frozen-thawed ET T A B L E 3 Characteristics and treatment outcomes of frozen cycles using assisted reproductive technology in Japan in 2015 Singleton, twin, triplet, and quaduplet pregnancies were defined according to the number of gestational sacs in utero. SET, single embryo transfer.
T A B L E 4 Treatment outcomes of registered cycles according to the patients' age in Japan in 2015 cycles reportedly result in better pregnancy and perinatal outcomes than fresh cycles, [7] [8] [9] and recently, strategies for fresh cycles using freeze-all embryos has been suggested. 10 In order to avoid the risk of ovarian hyperstimulation syndrome, fresh cycles with freeze-all embryos probably will increase in the future.
The strengths of the ART registry system in Japan are its mandatory reporting system and high compliance rate. Patients cannot receive a government subsidy for a cycle if their ART facility does not register the procedure. As almost all participating ART clinics and hospitals register cycle-specific information (99.3%), information on the latest clinical practices of ART in Japan are available. In contrast, the registry has several limitations. First, it includes multiple cycles for each patient over the years and it is impossible to distinguish cycles for a given patient; therefore, the correlations within a single patient could bias the clinical outcomes. Second, the registration of cycle-specific information and pregnancy outcomes depends on each ART facility; therefore, standardization of the data registration is important. Although JSOG publishes frequently asked questions and answers about registering data online and periodically scrutinizes these data in order to maintain their integrity, assessing the validity of the registry will continue to be very important in the future. 11, 12 In conclusion, this analysis of the ART registry for 2015 demonstrated that the total number of ART cycles increased and resulted in 51 001 neonates (1 in 19.7 neonates who were born in Japan). The patients' age when they received an ART procedure was higher than the mean age of primiparae in Japan. Single ET was performed at a rate of almost 80% and 96% of live births were singletons. The ET cycles have shifted from fresh to frozen cycles as fresh cycles with freeze-all embryos have increased. These data represent the latest clinical practices of ART in Japan and the registry has greatly contributed to improving the success and safety of ART in Japan.
T A B L E 5 Treatment outcomes of embryo transfers using frozen-thawed oocytes and assisted reproductive technology in Japan in 2015
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